No Data Yet
Based on his Q3 2025 13F filing, Carl Icahn established a new 3.64% portfolio stake in EchoStar (SATS) and fully divested his Bausch Health (BHC) position at $9 per share.
Alvotech (NASDAQ: ALVO) launched a $100 million convertible bond offering to fund its biosimilar pipeline and global expansion. The move comes as the company reaffirms 2025 guidance and sets ambitious 2026 targets, despite acknowledging potential U.S. regulatory delays.